文献速递慢性肾脏病遗传性与小管间质肾病

缺氧在肾脏中作用于APOL1

Hypoxia hits APOL1 in the kidney.
PubMed 文献 · Kidney Int · 2023-04-23

携带两个载脂蛋白1(APOL1)致病变异的非洲裔个体慢性肾脏病风险显著增加,但环境第二打击因素尚不明确。本研究发现缺氧或HIF脯氨酰羟化酶抑制剂稳定HIF后,可激活足细胞和肾小管细胞中APOL1的转录,且该上调与干扰素效应叠加。

要点

  • 缺氧或HIF脯氨酰羟化酶抑制剂通过稳定HIF激活足细胞和肾小管细胞中APOL1转录。
  • APOL1上游活性调控DNA元件与HIF相互作用,该增强子在肾脏细胞中优先可及。
  • HIF对APOL1的上调与干扰素效应叠加,提示缺氧打击可能调节APOL1肾病。

核心结论

  • 缺氧打击可能作为APOL1肾病的重要调节因素。

研究设计与样本

  • 基础实验研究,涉及足细胞、肾小管细胞及携带肾脏病风险变异个体尿液来源的肾小管细胞。

主要发现

  • 缺氧或HIF脯氨酰羟化酶抑制剂稳定HIF后激活足细胞和肾小管细胞中APOL1转录。
  • 鉴定出APOL1上游与HIF相互作用的活性调控DNA元件,该增强子在肾脏细胞中优先可及。
  • HIF对APOL1的上调与干扰素效应叠加。
  • HIF刺激携带肾脏病风险变异个体尿液来源肾小管细胞中APOL1表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Individuals of African ancestry carrying two pathogenic variants of apolipoprotein 1 (APOL1) have a substantially increased risk for developing chronic kidney disease. The course of APOL1 nephropathy is extremely heterogeneous and shaped by systemic factors such as a response to interferon. However, additional environmental factors operating in this second-hit model have been less well defined. Here, we reveal that stabilization of hypoxia-inducible transcription factors (HIF) by hypoxia or HIF prolyl hydroxylase inhibitors activates transcription of APOL1 in podocytes and tubular cells. An active regulatory DNA-element upstream of APOL1 that interacted with HIF was identified. This enhancer was accessible preferentially in kidney cells. Importantly, upregulation of APOL1 by HIF was additive to the effects of interferon. Furthermore, HIF stimulated expression of APOL1 in tubular cells derived from the urine of an individual carrying a risk variant for kidney disease. Thus, hypoxic insults may serve as important modulators of APOL1 nephropathy.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Grampp S, Krüger R, Lauer V, et al. Hypoxia hits APOL1 in the kidney. Kidney Int. 2023. PMID: 37098381. doi:10.1016/j.kint.2023.03.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。